Free Content Interleukin-12 and Tumour Necrosis Factor-α Equilibrium is a Prerequisite for Clinical Course Free from Late Complications in Children with Type 1 Diabetes Mellitus

Authors: Zorena, K.1; Myśliwska, J.1; Myśliwiec, M.2; Balcerska, A.2; Lipowski, P.3; Raczyńska, K.3

Source: Scandinavian Journal of Immunology, Volume 67, Number 2, February 2008 , pp. 204-208(5)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

The objective of the study was to analyse levels of IL-12 and TNF-α and relate the findings to the occurrence of microangiopathy in children with type 1 diabetes mellitus (DM). We examined a group of 123 children with type 1 DM. Serum levels of IL-12 and TNF-α were measured by an immunoenzymatic ELISA technique. TNF-α and IL-12 tended to be simultaneously present or absent in the sera of 50% of the children who had not developed complications, thus indicating a state of cytokine's equilibrium. Among the patients with an established retinopathy, two IL-12/TNF-α combinations were visible. Either a lack of detectable TNF-α was accompanied by measurable IL-12 serum concentrations or TNF-α incidence was associated with undetectable IL-12 values. Simultaneous lack of TNF-α and presence of IL-12 was associated with a better prognosis as these patients had a significantly lower albumin excretion rate. The state of equilibrium between TNF-α and IL-12 is beneficial in patients at early stages of the disease, prior to the occurrence of complications. Shifting the equilibrium towards TNF-α seems to promote late complications. It may suggest that a disharmony between pro- and anti-angiogenic function of these cytokines underlie the mechanism by which TNF-α and IL-12 shape the disease course.

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1365-3083.2007.02054.x

Affiliations: 1: Department of Immunology 2: Diabetological Department Clinic of Pediatrics, Hematology, Oncology and Endocrinology 3: Department and Clinic of Ophthalmology Medical University of Gdańsk, Gdańsk, Poland

Publication date: 2008-02-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page